Cent Eur Neurosurg 2008; 69(2): 80-86
DOI: 10.1055/s-2007-1022559
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Predictive Value of Intrathecal Interleukin-6 for Ventriculostomy-related Infection

Interleukin-6 als Vorhersagewert für Ventrikulostomie-assoziierte InfektionenB. Schoch 1 , J. P. Regel 1 , A. Nierhaus 2 , M. Wichert 3 , O. M. Mueller 1 , I. E. Sandalcioglu 1 , K. Mann 3 , D. Stolke 1
  • 1Department of Neurosurgery, University Hospital, Essen, Germany
  • 2Critical Care Medicine, University Hospital, Hamburg, Germany
  • 3Laboratory Medicine, University Hospital, Essen, Germany
Further Information

Publication History

Publication Date:
29 April 2008 (online)

Abstract

Background and Study Aim: Early diagnosis of ventriculostomy-related infection (VRI) is crucial for the early treatment and course of this disease. In neurosurgical patients the diagnostic criteria are equivocal, mostly because of bloodstained cerebrospinal fluid (CSF). The predictive value, sensitivity and specificity of intrathecal interleukin-6 (IL-6CSF) has been proven for VRI compared with classical diagnostic CSF parameters, i.e. cell countCSF (CCCSF) and total proteinCSF.

Patients and Methods: We prospectively analyzed the daily clinical data and CSF samples of 75 neurosurgical patients with an external ventricular drainage (EVD), which had been inserted predominantly because of poor-grade subarachnoid hemorrhage (SAH). The intrathecal interleukin-6 concentrations (IL-6CSF) were correlated with the clinical course and VRI incidence, as diagnosed by the classical VRI criteria (CCCSF, total proteinCSF, clinical symptoms).

Results: Based on classical criteria, bacterial meningitis occurred in 26.7% of patients. Patients with VRI manifested significantly (p<0.001) higher median values of IL-6CSF (up to 2000-fold increase) the day before (day -1) infection was diagnosed by conventional parameters. Using a cut-off value of IL-6CSF≥2700 pg/ml [4050 pg/ml after WHO standardization] on day -1, the relative risk for VRI was 6.09 (95% CI: 2.62-14.18%). A predictive value of IL-6CSF≥2700 pg/ml [4050 pg/ml] for VRI was calculated of 89% (95% CI: 79.6-98.0%), a sensitivity of 73.7% and a specificity of 91.4%. The amount of intrathecal blood was an independent risk factor for VRI occurrence, whereas the mean duration of EVD in place showed no impact on the rate of infection.

Conclusion: Our data indicate that IL-6CSF is a reliable marker for predicting VRI prior to clinically manifest meningitis, one day earlier than the common diagnostic criteria of CSF infection (CCCSF, total protein CSF, clinical symptoms).

Zusammenfassung

Einleitung: Die frühe Diagnosestellung einer Ventrikulostomie-assoziierten Infektion (VAI) ist von entscheidender Bedeutung für die Therapieeinleitung und damit dem weiteren Verlauf der Erkrankung. Im neurochirurgischen Patientengut sind die Kriterien zur Diagnosesicherung auf Grund der häufig blutigen Veränderung des Liquors unsicher. Ziel dieser Studie ist es, den Vorhersagewert für das Vorliegen einer VAI anhand von intrathekalem IL-6 (IL-6CSF) sowie die diesbezügliche Sensitivität und Spezifität zu untersuchen und mit den klassischen Liquorparametern Zellzahl (CCCSF) und Gesamteiweiß zu vergleichen.

Patienten und Methodik: Wir analysierten prospektiv tägliche klinische Parameter und Liquorproben von 75 konsekutiven neurochirurgischen Patienten mit externen Ventrikeldrainagen (EVD), deren Anlage zum überwiegenden Anteil auf Grund einer schweren Subarachnoidalblutung indiziert war. Die Konzentration des IL-6CSF wurde mit dem klinischen Verlauf und mit der Rate an VAI, die mit den klassischen Kriterien diagnostiziert worden waren (klinische Symptome, CCCSF, GesamteiweißCSF) korreliert.

Ergebnisse: Bei 26.7% der Patienten kam es zum Auftreten einer VAI. Patienten, die eine VAI entwickelten wiesen am Tag vor Diagnosestellung (Tag -1) signifikant höhere (p<0.001) IL-6CSF-Werte auf. Unter Zugrundelegung eines cut-off Wertes des IL-6CSF>2700 pg/ml [4050 pg/ml] am Tag-1 ergab sich für das Vorliegen einer VAI ein 6.09-fach höheres Risiko (95% CI: 2.62-14.18%). Der Vorhersagewert für IL-6CSF>2700 pg/ml [4050 pg/ml] für VAI lag bei 89% (95% CI: 79.6-98.0%), die Sensitivität bei 73.7%, die Spezifität bei 91.4%. Das Ausmaß an intrathekalem Blut war ein unabhängiger Risikofaktor für die Entwicklung einer VAI, wohingegen die Dauer der EVD keinen Einfluss auf die Rate an VAI hatte.

Schlussfolgerung: Unsere Daten weisen darauf hin, dass IL-6CSF als wichtiger Vorhersagemarker für das Vorliegen einer VAI anzusehen ist; und dies ist bereits einen Tag vor Änderungen der konventionellen diagnostischen Parameter (CCCSF, GesamteiweißCSF, klinische Symptome) festzustellen.

References

  • 1 Aihara Y, Kasuya H, Onda H, Hori T, Takeda J. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage.  Stroke. 2001;  32 212-217
  • 2 Asi-Bautista MC, Heidemann SM, Meert KL, Canady AI, Sarnaik AP. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 concentrations in cerebrospinal fluid predict ventriculoperitoneal shunt infection.  Crit Care Med. 1997;  25 1713-1716
  • 3 Bogdahn U, Lau W, Hassel W, Gunreben G, Mertens HG, Brawanski A. Continuous - pressure controlled, external ventricular drainage for treatment of acute hydrocephalus - evaluation of risk factors.  Neurosurgery. 1992;  31 898-903 , ; discussion 903-894
  • 4 Bota DP, Lefranc F, Vilallobos HR, Brimioulle S, Vincent JL. Ventriculostomy-related infections in critically ill patients: a 6-year experience.  J Neurosurg. 2005;  103 468-472
  • 5 Brown JM, Grosso MA, Harken AH. Cytokines, sepsis and the surgeon.  Surg Gynecol Obstet. 1989;  169 568-575
  • 6 Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation.  Neurosurgery. 2003;  53 123-133 , ; discussion 133-135
  • 7 Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, Fritzinger M, Horn P, Vajkoczy P, Kreisel S, Brunner J, Schmiedek P, Hennerici M. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries.  J Neurol Neurosurg Psychiatry. 2001;  70 534-537
  • 8 Fassbender K, Ragoschke A, Kuhl S, Szabo K, Fatar M, Back W, Bertsch T, Kreisel S, Hennerici M. Inflammatory leukocyte infiltration in focal cerebral ischemia: unrelated to infarct size.  Cerebrovasc Dis. 2002;  13 198-203
  • 9 Fassbender K, Ries S, Schminke U, Schneider S, Hennerici M. Inflammatory cytokines in CSF in bacterial meningitis: association with altered blood flow velocities in basal cerebral arteries.  J Neurol Neurosurg Psychiatry. 1996;  61 57-61
  • 10 Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.  Neurosurgery. 1980;  6 1-9
  • 11 Frei K, Nadal D, Fontana A. Intracerebral synthesis of tumor necrosis factor-alpha and interleukin-6 in infectious meningitis.  Ann N Y Acad Sci. 1990;  594 326-335
  • 12 Gaetani P, Tartara F, Pignatti P, Tancioni F, Rodriguez y Baena R, De Benedetti F. Cisternal CSF levels of cytokines after subarachnoid hemorrhage.  Neurol Res. 1998;  20 337-342
  • 13 Greenberg MS. Handbook of Neurosurgery. 4th ed. Greenberg Graphics Inc., Lakeland, Florida 1997
  • 14 Hashim IA, Walsh A, Hart CA, Shenkin A. Cerebrospinal fluid interleukin-6 and its diagnostic value in the investigation of meningitis.  Ann Clin Biochem. 1995;  32 ((Pt 3)) 289-296
  • 15 Holloway KL, Barnes T, Choi S, Bullock R, Marshall LF, Eisenberg HM, Jane JA, Ward JD, Young HF, Marmarou A. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients.  J Neurosurg. 1996;  85 419-424
  • 16 Iadecola C, Alexander M. Cerebral ischemia and inflammation.  Curr Opin Neurol. 2001;  14 89-94
  • 17 Kleine TO, Zwerenz P, Zofel P, Shiratori K. New and old diagnostic markers of meningitis in cerebrospinal fluid (CSF).  Brain Res Bull. 2003;  61 287-297
  • 18 Lozier AP, Sciacca RR, Romagnoli MF, Connolly Jr ES. Ventriculostomy-related infections: a critical review of the literature.  Neurosurgery. 2002;  51 170-181 , ; discussion 181-172
  • 19 Mathiesen T, Andersson B, Loftenius A, Holst H von. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage.  J Neurosurg. 1993;  78 562-567
  • 20 Mayhall CG, Archer NH, Lamb VA, Spadora AC, Baggett JW, Ward JD, Narayan RK. Ventriculostomy-related infections. A prospective epidemiologic study.  N Engl J Med. 1984;  310 553-559
  • 21 Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial.  Lancet. 2002;  360 1267-1274
  • 22 Mukai AO, Krebs VL, Bertoli CJ, Okay TS. TNF-alpha and IL-6 in the diagnosis of bacterial and aseptic meningitis in children.  Pediatr Neurol. 2006;  34 25-29
  • 23 Muller M, Schwerdtfeger K, Maier B, Mautes A, Schiedat T, Bianchi O, Marzi I. Cerebral blood flow velocity and inflammatory response after severe traumatic brain injury.  Eur J Ultrasound. 2001;  12 203-208
  • 24 Narayan RK, Kishore PR, Becker DP, Ward JD, Enas GG, Greenberg RP, Domingues Da Silva A, Lipper MH, Choi SC, Mayhall CG, Lutz 3rd HA, Young HF. Intracranial pressure: to monitor or not to monitor? A review of our experience with severe head injury.  J Neurosurg. 1982;  56 650-659
  • 25 Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M, Shibuya M, Yoshida J. Interleukin-6 and development of vasospasm after subarachnoid haemorrhage.  Acta Neurochir (Wien). 1998;  140 943-951
  • 26 Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization.  Neurology. 1992;  42 289-298
  • 27 Schade RP, Schinkel J, Roelandse FW, Geskus RB, Visser LG, Dijk MC Van, Voormolen JH, Pelt H Van, Kuijper EJ. Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis.  J Neurosurg. 2006;  104 101-108
  • 28 Schade RP, Schinkel J, Visser LG, Dijk JM Van, Voormolen JH, Kuijper EJ. Bacterial meningitis caused by the use of ventricular or lumbar cerebrospinal fluid catheters.  J Neurosurg. 2005;  102 229-234
  • 29 Schoch B, Regel JP, Wichert M, Gasser T, Volbracht L, Stolke D. Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage.  Neurosurgery. 2007;  60 828-836 , ; discussion 828-836
  • 30 Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage.  Jpn J Pharmacol. 2002;  88 227-249
  • 31 Sundbarg G, Nordstrom CH, Soderstrom S. Complications due to prolonged ventricular fluid pressure recording.  Br J Neurosurg. 1988;  2 485-495
  • 32 Taskin E, Turgut M, Kilic M, Akbulut H, Aygun AD. Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis.  Mediators Inflamm. 2004;  13 269-273
  • 33 Teasdale GM, Drake CG, Hunt W, Kassell N, Sano K, Pertuiset B, Villiers JC De. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies.  J Neurol Neurosurg Psychiatry. 1988;  51 1457
  • 34 Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.  J Exp Med. 1989;  170 1859-1867
  • 35 Winfield JA, Rosenthal P, Kanter RK, Casella G. Duration of intracranial pressure monitoring does not predict daily risk of infectious complications.  Neurosurgery. 1993;  33 424-430 , ; discussion 430-431
  • 36 Woiciechowsky C, Asadullah K, Nestler D, Glockner F, Robinson PN, Volk HD, Vogel S, Lanksch WR. Different release of cytokines into the cerebrospinal fluid following surgery for intra- and extra-axial brain tumours.  Acta Neurochir (Wien). 1997;  139 619-624

Correspondence

B. SchochMD 

Department of Neurosurgery

University Hospital

Hufelandstr. 55

45147 Essen

Germany

Phone: +49/291/723 12 37

Fax: +49/291/723 12 41

Email: beate.schoch@uk-essen.de

    >